Skip to main content
. 2023 Oct 23;14:6699. doi: 10.1038/s41467-023-42360-w

Fig. 3. Clinical relevance of CDK6 in HCC.

Fig. 3

a By analysis of the GSE25097 dataset10, we found upregulation of CDK6 mRNA in a cohort of human HCC samples (tumor n = 268 and adjacent non-tumor n = 243). In addition, CDK6 was upregulated in cirrhotic samples (n = 40) compared to healthy donors (n = 6) (two-tailed t test). b A tissue microarray consisting of 51 tumor tissues and corresponding non-tumor liver tissues was subjected to IHC analysis. Case 8 showed low expression of CDK6, while case 20 showed high expression of this protein. Scale bars = 50 µm and 200 µm. c Patients with high CDK6 expression (n = 21) had shorter disease-free survival than those with low expression (n = 21) (p = 0.0412; log-rank test). High-CDK6 expression was significantly correlated with HCC recurrence (p = 0.0078; χ2 test). Data was presented as mean ± standard deviation. Source data are provided as a Source Data file.